
Cellarian is a SaaS health IT company focused on automating medical necessity documentation for diagnostic labs. Founded by a physician and a team of industry and health IT specialists, Cellarian addresses the problem of revenue loss due to inadequate documentation for lab services, particularly in drug testing. Their solution streamlines the process of generating patient-specific clinical documentation, prior authorizations, and claim appeals, integrating with EHRs and Lab Information Systems. This automation helps labs reduce denial management costs, improve operational efficiency, and capture previously unreachable revenue, ensuring compliance with insurance medical necessity requirements and industry standards. The company's adaptable, modular software design can be expanded to various lab service lines and offers a significant ROI at scale, without adding extra work for providers.

Cellarian is a SaaS health IT company focused on automating medical necessity documentation for diagnostic labs. Founded by a physician and a team of industry and health IT specialists, Cellarian addresses the problem of revenue loss due to inadequate documentation for lab services, particularly in drug testing. Their solution streamlines the process of generating patient-specific clinical documentation, prior authorizations, and claim appeals, integrating with EHRs and Lab Information Systems. This automation helps labs reduce denial management costs, improve operational efficiency, and capture previously unreachable revenue, ensuring compliance with insurance medical necessity requirements and industry standards. The company's adaptable, modular software design can be expanded to various lab service lines and offers a significant ROI at scale, without adding extra work for providers.
What they do: Automated medical-necessity documentation, prior-authorization completion, and denials management for diagnostic laboratories (initial focus on toxicology/drug testing)
Headquarters: Houston
Founder / CEO: Michael Sprintz, DO
Employees (approx.): 5
Known funding (reported): 2,770,000 USD (last noted 2017-04-01)
Revenue loss and compliance risk from inadequate payer medical-necessity documentation and denials for diagnostic lab services (initial focus on drug/toxicology testing).
Health IT / SaaS
2770000.00